Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOralGeneric

RANITIDINE

RANITIDINE

Standard Dose
15MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview RANITIDINE is listed in Drugs@FDA under application 074794 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient RANITIDINE Form and strength Solution; Oral - 15MG/ML Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 1997-11-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview RANITIDINE is listed in Drugs@FDA under application 074794 (ANDA). Marketing status: None (Tentative Approval) Active ingredient RANITIDINE Form and strength Solution; Oral - 15MG/ML Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 1997-11-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.